logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/05/2025
Baird: Maintain a rating of Outperform for Karyopharm Therapeutics (KPTI.US), adjusting from Market Outperform to Outperform. The target price is adjusted from $54.00 to $42.00.
Latest
1 m ago
An executive stated that United Airlines may not receive the Boeing 737 MAX 10 aircraft until 2027 or 2028.
1 m ago
An executive stated that United Airlines may not receive the Boeing 737 MAX 10 aircraft until 2027 or 2028.
2 m ago
AMD and Humain have reached a strategic cooperation agreement worth 10 billion dollars to promote the development of artificial intelligence worldwide.
2 m ago
AMD and Huiman reached a $10 billion strategic cooperation to drive global artificial intelligence development.
2 m ago
Piper Sandler: Maintains rating on Exxon Mobil (XOM.US) and adjusts from hold to buy rating, with target price adjusted from $127.00 to $125.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.